In Depth 10 Jun 2024
ASCO 2024: The latest advances in oncology clinical trials
Biotechs from all over the country as well as other parts of the world showcased recent pipeline advancements in oncology clinical trials at ASCO 2024.
- Latest Posts
Best in Biotech 7 Jun 2024
5 universities offering a Masters in biotechnology in France
Take a look at five universities offering a Masters in biotechnology in France, paving the way for students to begin their careers in the biotech industry.
Podcast 7 Jun 2024
Hope for tomorrow: Developing treatments for rare pediatric diseases
On this week’s podcast we are discussing novel treatments of rare pediatric diseases with Dan Williams, CEO, executive director of Synaptix Bio.
In Depth 6 Jun 2024
CRISPR: A promising path to treating blindness
Rigorous research, which has been going on for more than a decade now, suggests that CRISPR could treat genetic diseases including blindness.
Best in Biotech 6 Jun 2024
Eight biotech companies advancing the field of siRNA
Explore the growing sector of siRNA and discover eight biotech companies spearheading this innovative field.
In Depth 5 Jun 2024
Evolving standards of care: new treatments for cervical cancer
New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 4 Jun 2024
Ohio’s finest: Eight biotech companies leading the way
While Ohio has a strong emphasis on manufacturing, the state is home to several innovative biotech companies.
In Depth 3 Jun 2024
The biggest private biotech investments in May 2024
The companies Uniquity Bio, AltruBio, and BridgeBio Oncology Therapeutics bagged the biggest private biotech investments in May 2024.
Best in Biotech 31 May 2024
Biotech career fairs in the U.S. you don’t want to miss
Biotech career fairs are held to connect talent with professionals and recruiters. Here are six popular events that take place annually in the U.S.
Podcast 31 May 2024
Can cell therapy tackle hearing loss
Hearing loss is a growing global challenge. UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss.
In Depth 30 May 2024
Covalent biologics: a new class of drugs on the horizon
The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic.
Best in Biotech 30 May 2024
Stem cell therapy’s avant-garde: Eight companies leading the way
Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field.
ADVERTISEMENT
